Savvy Updates, 8/12/24: Medtronic Simplera CGM Approved, Medtronic/Abbott CGM Integration, Diabeloop Study on Disparities in Insulin Needs Between Sexes, Accu-Chek SmartGuide Approved in Europe, Most Downloaded Apps to Manage T1D

Savvy Updates, 8/12/24: Medtronic Simplera CGM Approved, Medtronic/Abbott CGM Integration, Diabeloop Study on Disparities in Insulin Needs Between Sexes, Accu-Chek SmartGuide Approved in Europe, Most Downloaded Apps to Manage T1D

FDA approves next-generation CGM with two-step insertion process by Jill Rollet for Healio.com/endocrinology, 7 August 2024. FDA approved Medtronic’s next-generation continuous glucose monitor for people with diabetes.  The Simplera CGM (Medtronic) is a CGM...
Savvy Updates, 8/5/24:  Tandem Mobi Expansion Plans, T1D Vision/Hearing Loss Need Access to D Tech, More on Dexcom & Geofencing, Spotlight on Creativity: Krista Sheneman

Savvy Updates, 8/5/24: Tandem Mobi Expansion Plans, T1D Vision/Hearing Loss Need Access to D Tech, More on Dexcom & Geofencing, Spotlight on Creativity: Krista Sheneman

Tandem CMO shares Mobi feedback, expansion plans by Elise Reuter for MedTechDive.com, 29 July 2024. Tandem Diabetes Care this year began a full launch of its smallest insulin pump, called Mobi, after the device received clearance from the Food and Drug Administration...
Savvy Updates 7/29/24:  Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Savvy Updates 7/29/24: Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Abbott Issues Warning for Certain FreeStyle Libre 3 Sensors by Paul Heltzel for diaTribe.org, 25 July 2024. Some FreeStyle Libre 3 continuous glucose monitoring sensors could display false high readings and should be immediately discontinued, urged the manufacturer....
Savvy Updates 7/22/24: ALERT: Dexcom G7 & Geofencing, Sensulin Glucose-Responsive Insulin, Bulsai Infrared Sensor for Placing for Insulin Injections, iAPS/Trio DIY Insulin Algorithm, Replica Health Personalized Metabolic Healthcare, Free Lifetime US National Parks Pass

Savvy Updates 7/22/24: ALERT: Dexcom G7 & Geofencing, Sensulin Glucose-Responsive Insulin, Bulsai Infrared Sensor for Placing for Insulin Injections, iAPS/Trio DIY Insulin Algorithm, Replica Health Personalized Metabolic Healthcare, Free Lifetime US National Parks Pass

Dexcom G7 & Geofencing: Travel Alert If you are a Dexcom G7 user or using MDI with connection to phone app, PLEASE READ: you are planning travel shortly away from your home country, and you use open-source DIY app or MDI or Mobi or will use O5 with G7 Dexcom G7 is...
Savvy Updates 7/15/24:  Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
Skip to content